<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04515498</url>
  </required_header>
  <id_info>
    <org_study_id>CC-P-001</org_study_id>
    <nct_id>NCT04515498</nct_id>
  </id_info>
  <brief_title>A Prospective Clinical Study of the CloudCath System During In-home Peritoneal Dialysis</brief_title>
  <acronym>CATCH</acronym>
  <official_title>A Prospective Clinical Study of the Ability of the CloudCath System to Detect Peritonitis During In-home Peritoneal Dialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CloudCath</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CloudCath</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine if the CloudCath device can detect infections related to&#xD;
      peritoneal dialysis (peritonitis) as fast or faster than the current standard methods used by&#xD;
      patients and doctors to detect such infections.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate the safety and effectiveness of the CloudCath System to detect the&#xD;
      onset of peritonitis as compared to standard of care.&#xD;
&#xD;
      Study Participants will connect the CloudCath System to their home peritoneal dialysis unit&#xD;
      and the CloudCath System will analyze the effluent dialysis solution for changes associated&#xD;
      with peritonitis. The notification capability of the CloudCath System will be deactivated for&#xD;
      this study so that neither Study Participants nor Study Investigators will be aware of the&#xD;
      device measurements.&#xD;
&#xD;
      Following enrollment, Study Participants will use the CloudCath System for 12 continuous&#xD;
      months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">August 19, 2020</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time of peritonitis detection (vs lab measures)</measure>
    <time_frame>through 12 months</time_frame>
    <description>The time peritonitis is detected by the CloudCath System, as compared to time of laboratory evidence of peritonitis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time of peritonitis detection (vs clinical measures)</measure>
    <time_frame>through 12 months</time_frame>
    <description>The time peritonitis is detected by the CloudCath System, as compared to time of peritonitis detection by standard clinical means (ISPD guidelines)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and specificity of the CloudCath System detection of peritonitis</measure>
    <time_frame>through 12 months</time_frame>
    <description>Analysis of sensitivity and specificity of CloudCath System detection of peritonitis, as compared to diagnostic laboratory testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ability of study participants to use the CloudCath System as intended</measure>
    <time_frame>through 12-months of study follow-up</time_frame>
    <description>Device performance measure; ability to use as intended</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Sensitivity and specificity of the CloudCath System detection of peritonitis and the resolution of peritonitis</measure>
    <time_frame>through 12 months</time_frame>
    <description>Analysis of sensitivity and specificity of the detection of peritonitis and the detection of the resolution of peritonitis, as compared to diagnostic laboratory testing</description>
  </other_outcome>
  <other_outcome>
    <measure>Sensitivity and specificity of the CloudCath System detection of resolution of peritonitis</measure>
    <time_frame>through 12 months</time_frame>
    <description>Analysis of sensitivity and specificity of the resolution time of peritonitis</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">186</enrollment>
  <condition>Peritoneal Dialysis-associated Peritonitis</condition>
  <arm_group>
    <arm_group_label>CloudCath System</arm_group_label>
    <description>Patients with End Stage Renal Disease (ESRD) currently using home peritoneal dialysis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CloudCath Monitoring System</intervention_name>
    <description>The CloudCath Monitoring System will analyze effluent dialysate for changes associated with peritonitis.</description>
    <arm_group_label>CloudCath System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients currently using home peritoneal dialysis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  currently using peritoneal dialysis&#xD;
&#xD;
          -  provides informed consent&#xD;
&#xD;
          -  willing to comply with the requirements of the study&#xD;
&#xD;
          -  has cellular data coverage at home&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  active or history of cancer requiring chemotherapy within prior 6 months&#xD;
&#xD;
          -  signs or symptoms of an active infection within 14 days prior to enrollment&#xD;
&#xD;
          -  peritonitis diagnosis within 30 days prior to enrollment&#xD;
&#xD;
          -  participating in another investigational device or drug study that may potentially&#xD;
             affect study results&#xD;
&#xD;
          -  other medical, social or psychological problems that, in the opinion of the&#xD;
             investigator, exclude the study participant from the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glenn Chertow, MD</last_name>
    <role>Study Director</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CloudCath Investigational Site</name>
      <address>
        <city>Lakewood</city>
        <state>Colorado</state>
        <zip>80226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 13, 2020</study_first_submitted>
  <study_first_submitted_qc>August 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2020</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peritonitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

